Steve Slilaty's most recent trade in Sunshine Biopharma Inc was a trade of 100,000 Series B Preferred Stock done at an average price of $0.1 . Disclosure was reported to the exchange on March 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine Biopharma Inc | Steve Slilaty | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.10 per share. | 04 Mar 2024 | 100,000 | 130,000 | - | 0.1 | 10,000 | Series B Preferred Stock |
| Sunshine Biopharma Inc | Slilaty Steve | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.10 per share. | 08 Feb 2024 | 20,000 | 30,000 | - | 0.1 | 2,000 | Series B Preferred Stock |
| Sunshine Biopharma Inc | Steve Slilaty | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.10 per share. | 18 Feb 2022 | 990,000 | 10,000 | - | 0.1 | 99,000 | Series B Preferred Stock |